Skip to Main

Search

Results 161 to 170 of 1,030 for ""

UTSW Pharmacologist James Collins receives 2023 TAMEST Edith and Peter O’Donnell Award: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/january-tamest-collins.html

James Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center, will receive the 2023 Edith and Peter O’Donnell Award in Biological Sciences from The Academy of Medicine, Engineering and Science of Texas (TAMEST) for broadening understanding of schistosomiasis, a disease caused by parasitic worms that infect hundreds of millions of the world’s poorest and most vulnerable people, including children.

Drug targeting clear cell renal cell carcinoma shows promising approach: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/april-drug-targeting.html

– In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center, a short interfering RNA (siRNA) drug directed to tumor cells, ARO-HIF2, effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma (ccRCC).

UTSW study finds cognitive decline key factor in predicting life expectancy in Alzheimer’s disease: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/cognitive-decline.html

Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from researchers at UT Southwestern.

More than 97% of UT Southwestern medical students match to residency programs nationally, across Texas : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/match-day.html

More than 200 UT Southwestern medical students matched to more than 80 programs across the nation, including Harvard, Yale, and Johns Hopkins, as well as a dozen medical programs across Texas.

UT Southwestern campaign infuses $1B into Peter O’Donnell Jr. Brain Institute : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/obi-philanthropic-campaign.html

UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.

UTSW faculty addresses challenges of diagnosing heart attacks in New England Journal of Medicine: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/diagnosing-heart-attacks.html

Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients.

UT Southwestern Medical Center named Official Healthcare Partner of PGA Frisco: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/pga-frisco.html

The PGA of America and Omni Hotels & Resorts today announced a new six-year partnership with UT Southwestern Medical Center, naming the hospital as the “Official Healthcare Partner of PGA Frisco.” The relationship will begin in 2023, to coincide with the official opening of PGA Frisco and Omni PGA Frisco Resort.

High CAC, high cholesterol increase heart attack/stroke risk, UT Southwestern cardiologists find: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/high-cac.html

Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a more than 20% higher risk of heart attack or stroke over the following 10 years, according to findings from a multicenter study led by preventive cardiologists at UT Southwestern Medical Center.

UTSW study finds blood pressure rose during the pandemic: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/blood-pressure.html

Blood pressure rose moderately during the early months of the pandemic, according to a UT Southwestern study of patients who monitored themselves at home.

Study offers insight into management of patients who have interstitial pneumonia with autoimmune features : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-interstitial-pneumonia.html

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat. While immunosuppressant drugs are primarily prescribed, they don’t work for all patients.